Ho C-M, Cheng W-F, Chu T-Y, Chen C-A, Chuang M-H, Chang S-F, Hsieh C-Y
Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Cathay General Hospital, Taipei, Taiwan, ROC.
Br J Cancer. 2006 Nov 20;95(10):1384-9. doi: 10.1038/sj.bjc.6603430. Epub 2006 Oct 24.
To better predict risk of progression of low-grade squamous intraepithelial lesions (LSILs) of the uterine cervix in women with human papillomavirus (HPV) infections, 294 baseline cervical specimens from women with LSILs were evaluated. Specimens were tested for HPV DNA using hybrid capture 2 (HC2) and PCR-reverse line blotting. 65 LSILs with HPV DNA types 16, 18, 52, or 58 were examined for physical status, E2/E6 ratio and viral load at two time points, along with patient age. Women with LSILs whose viral loads increased between baseline and 6 month follow-up had a 45% risk of developing HSIL (OR=7.6, 95% CI=1.9-29.4, P<0.01), as evaluated by real-time PCR and a 44% risk (OR=6.1, 95% CI=1.6-22.7, P<0.01), as evaluated by HC2. The two viral load measures correlated well (Person's coefficient, r=0.687, P<0.001). Such evaluations of viral load changes (increased or not increased) through repeat HPV DNA testing could predict progression of disease in LSIL cases of HPV types 16, 18, 52, and 58, which correlates to clinical implications.
为了更好地预测人乳头瘤病毒(HPV)感染女性子宫颈低度鳞状上皮内病变(LSIL)的进展风险,对294例LSIL女性的基线宫颈标本进行了评估。使用杂交捕获2(HC2)和PCR反向线印迹法检测标本中的HPV DNA。对65例感染HPV 16、18、52或58型的LSIL患者在两个时间点检查其身体状况、E2/E6比值和病毒载量,并记录患者年龄。通过实时PCR评估,在基线和6个月随访期间病毒载量增加的LSIL女性发生高级别鳞状上皮内病变(HSIL)的风险为45%(OR=7.6,95%CI=1.9-29.4,P<0.01);通过HC2评估,风险为44%(OR=6.1,95%CI=1.6-22.7,P<0.01)。两种病毒载量测量方法相关性良好(Person系数,r=0.687,P<0.001)。通过重复HPV DNA检测评估病毒载量变化(增加或未增加),可以预测HPV 16、18、52和58型LSIL病例的疾病进展,这具有临床意义。